Updates on Brexpiprazole for Pediatric Patients With Schizophrenia

Drug Topics sister site Contemporary Pediatrics sat down with Abigail Donovan, MD, assistant professor of psychiatry at Massachusetts General Hospital in Boston to discuss brexpiprazole, which recently received a supplemental new drug application from the US Fod and Drug Administration for use in patients aged 13 to 17 years. She discussed what it brings to the table, the adverse effects it can cause, and who is likely to prescribe it.